Newly formed biotech company with fresh capital
The Swedish company Galecto Biotech, lead by Dane Hans Schambye, has brought two additional investors on board, one of which signals the first investment from a new investment fund.
Seed Capital and Sunstone Capital now join the list of investors in the newly formed biotech company Galecto Biotech. Novo A/S and Merck Serono Ventures have already posted capital in the company, which is headed by Dane Hans Schambye.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Less venture-money for zealous companies
For abonnenter
